Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2023-04-28 Major Shareholding Noti…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed with the Korean regulatory authority. It details specific changes in share ownership by major shareholders and related parties, including the number of shares sold and the resulting change in ownership percentage. This falls under the category of Major Shareholding Notification as it tracks significant ownership changes.
2023-04-28 Korean
주요사항보고서(자기전환사채매도결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Services Commission in South Korea. It specifically details the company's decision to sell its own convertible bonds (자기전환사채매도결정). This type of corporate action, involving the disposal of financial instruments or capital structure adjustments, falls under the 'Capital/Financing Update' category. It is not a general regulatory filing as it has a specific, identifiable purpose related to financing activities.
2023-04-21 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system (KIND) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the acquisition of a patent in Singapore. Since this is a standard regulatory disclosure for material corporate events that does not fit into specific categories like financial reports, M&A, or dividends, it is classified as a general Regulatory Filing (RNS).
2023-04-17 Korean
주권관련사채권의취득결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing titled '주권 관련 사채권의 취득결정' (Decision on Acquisition of Equity-Related Bonds), which details the issuance of convertible bonds by a subsidiary. It includes specific financial terms, conversion prices, interest rates, and board resolution details. This type of disclosure is a standard regulatory filing in the Korean market (DART system) regarding capital structure changes and financing activities, fitting the 'Capital/Financing Update' category.
2023-04-13 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a structured summary of the resolutions passed during the meeting, including financial statement approval, dividend status, and board appointments. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), which reports the official outcomes of shareholder votes at a general meeting.
2023-04-04 Korean
[기재정정]타법인주식및출자증권취득결정
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous decision to acquire shares in another company (타법인 주식 및 출자증권 취득결정). This type of filing details changes to investment terms, such as the number of shares, acquisition price, and expected acquisition date. Since it is a formal regulatory disclosure of a corporate transaction (M&A/Investment activity) and does not fit into specific categories like 'Earnings Release' or 'Annual Report', it is classified as a Regulatory Filing (RNS).
2023-04-04 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.